Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Glaxosmithkline Plc (NY: GSK )

37.45 USD -0.33 (-0.87%)
Streaming Delayed Price Updated: 8:49 AM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Glaxosmithkline Plc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Why Surface Oncology Stock Sank Today
Investors reacted negatively to a big licensing deal. 
Tags Market News GSK SURF
From Motley Fool
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BASI IBB SMMT
From Benzinga
Before The Blizzard
Money is moving away from stocks and into alternatives like Bitcoin, cannabis plays, and gold. The reason is very high COVID-19 hospitalizations and deaths. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Markets Up As US Clears Path For Moderna Vaccine Approval
European markets have opened positively this morning with Germany’s Dax leading the way up 1.6% as optimism creeps in surrounding vaccination and the prospect of US fiscal stimulus ahead of Central... 
Tags Financial Healthcare Cryptocurrencies
From Blogs - TalkMarkets
Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna
The challenges for two big drugmakers could translate to opportunities for their rivals in the COVID-19 vaccine race. 
Tags SNY MRNA PFE
From Motley Fool
Dr. Fauci says Biden and Harris should receive COVID-19 vaccination ‘as soon as we possibly can’
Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said, ‘You still want to protect people who are very important to our country right now.’ 
Tags DIS SNY Travel
From MarketWatch
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GSK VERU EVLO
From Benzinga
‘Flight to safety’: COVID-19 has made Americans rethink the kinds of places they want to work
‘The COVID-19 pandemic shifted the focus of job-seekers,’ a new study says. 
Tags Media SPX COMP
From MarketWatch
CureVac starts Phase 3 clinical trial of its Covid-19 vaccine candidate
Tübingen-based CureVac said the Phase 3 trial will include more than 35,000 volunteers in Europe and Latin America 
Tags UK:0Q1N GSK BNTX
From MarketWatch
European stocks and U.S. equity futures rise on COVID-19 vaccine optimism and hopes for a Washington stimulus deal
Stocks in Europe are kicking off the week with gains, as investors look on the brighter side, with optimism over vaccine rollouts and a stimulus deal out of Washington. The extension of Brexit talks... 
Tags RDS/A PFE XX:SXXP
From MarketWatch
Negative News Day
The UK and the EU are unlikely to reach a deal by the Sunday deadline, so Britain will do a no-deal exit from the European Community. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Powerhouse Duo GSK, Sanofi Delay Covid Vaccine And Shares Tumble
GlaxoSmithKline and Sanofi delayed their coronavirus vaccine on Friday after the drug showed little benefit in older adults. The news sent GSK stock and Sanofi stock tumbling. 
From Investor's Business Daily
Is Pfizer Stock A Buy After FDA Promises To 'Rapidly' Authorize Covid Vaccine?
Pfizer stock was under pressure in mid-December as investors awaited a Food and Drug Administration decision over its BioNTech-partnered coronavirus vaccine. But is the stock a buy now? 
From Investor's Business Daily
Sanofi and GlaxoSmithKline Delay COVID-19 Vaccine Program Due to Poor Immune Response in Older Adults
The vaccine giants will be rethinking the formulation of their coronavirus candidate before a new phase 2 study. 
Tags MRNA PFE SNY
From Motley Fool
U.S. suffers worst week for cases, deaths and hospitalizations since start of the pandemic
The U.S. suffered its worst week for cases, deaths and hospitalizations with the coronavirus illness COVID-19, as the Food and Drug Administration said it would grant emergency use authorization to the... 
Tags MRNA PFE Biotechnology
From MarketWatch
With Brexit talks on the line, London stocks and the pound simultaneously suffer
A weak pound isn’t helping London stocks, with investors nervously looking toward a weekend deadline for a post-Brexit trade deal. Banks and oil companies are sliding. 
Tags UK:RR UK:0Q1N FR:SAN
From MarketWatch
Sanofi, GSK Delay COVID Vaccine On Low Response In Older Adults
Sanofi and GlaxoSmithKline announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags News GSK EIDX
From Benzinga
Dow poised to skid 200 point amid setbacks on U.S. fiscal relief package and Brexit
U.S. stock indexes were indicated lower on Friday, wrapping up a week that has been focused on uncertain progress toward another coronavirus relief package by Congress and thus far unsuccessful... 
Tags AU:CSL XX:DLW1IDUA GSK
From MarketWatch
There’s one reason big growth stocks have outperformed over the last decade — and that’s about to change, strategist says
Scott Opsal, director of equities for Leuthold Weeden Capital Management in Minneapolis, says value, small-caps and emerging markets share similar characteristics as anti-large growth rotation plays. 
Tags GSK XX:891800 BX:TMUBMUSD10Y
From MarketWatch
A Peek Into The Markets: US Stock Futures Down; Pfizer Covid-19 Vaccine Gets FDA Panel's Nod
Pre-open movers U.S. stock futures traded lower in early pre-market trade following a delay in the Covid-19 relief package. Pfizer ... 
Tags A Peek Into The Markets GSK News
From Benzinga
Daily Stock Analysis: GlaxoSmithKline
GSK's price per share closed at $37.98 yesterday. A year ago its price was $46.29. 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
European stocks stumble on COVID-19 vaccine setback, while U.S. equity futures fall on stimulus worries
European stocks fell Friday, alongside U.S. equity futures as investors watch Brexit, vaccines and U.S. stimulus progress. 
Tags UK:UKX XX:SXXP PFE
From MarketWatch
GSK-Sanofi COVID-19 Vaccine Shows Insufficient Immunity, Late-Stage Trials Delayed
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NYSE: GSK) on Friday reported a delay in their COVID-19 vaccine program as interim ... 
Tags Vaccines General Covid/19
From Benzinga
It Will All End In Tears
As hopes for a Brexit deal sink, the pound sterling is down, giving a boost to UK stocks earning foreign currency while Wall Street is again downing the Dow. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Emerging Markets Hit Record High: 5 Top-Performing ETFs YTD
While many emerging market ETFs have been performing remarkably well, here are five funds that are leading the space on a year-to-date basis. 
Tags ETFs
From Blogs - TalkMarkets
Toppy New Stock Issues Coming
Pfizer fell today despite inoculations begun in Britain. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Dr. Fauci warns of ‘dark time’ for COVID-19 after Christmas and Hanukkah surge
‘This may be even more compounded because it’s a longer holiday,’ Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said. 
Tags Entertainment and Leisure MRNA PFE
From MarketWatch
Pearl Harbor Day
With new corona-virus lockdowns, the price of oil has fallen. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Americans prepare to travel again for Christmas, while hospitals brace for ‘bad outcomes’ post-Thanksgiving
The U.S. set a record for COVID-19-related hospitalizations this month with more than 100,000 patients, and the number of people with the virus in intensive-care units surpassing 20,000. 
Tags AZN DJIA BNTX
From MarketWatch
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.